Lataa...
Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
BACKGROUND: Infliximab is a chimeric anti-tumor necrosis factor alpha (TNF-α) monoclonal antibody that ameliorates inflammation when it binds to and neutralizes TNF-α. It is often used in patients with Crohn’s disease and ulcerative colitis to reduce the severity of disease symptoms and induce disea...
Tallennettuna:
| Julkaisussa: | Dig Dis Sci |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer US
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6394553/ https://ncbi.nlm.nih.gov/pubmed/30311152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-018-5319-6 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|